TrialBreast cancer research : BCR2014

Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.

Karin Beelen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.